117 related articles for article (PubMed ID: 30771605)
1. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
Yao BR; Sun Y; Chen SL; Suo HD; Zhang YL; Wei H; Wang CH; Zhao F; Cong W; Xin WY; Hou GG
Eur J Med Chem; 2019 Apr; 167():187-199. PubMed ID: 30771605
[TBL] [Abstract][Full Text] [Related]
2. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine.
Sun Y; Gao ZF; Yan WB; Yao BR; Xin WY; Wang CH; Meng QG; Hou GG
Eur J Med Chem; 2020 Jul; 198():112366. PubMed ID: 32371335
[TBL] [Abstract][Full Text] [Related]
4. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
5. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation.
Su CM; Hou GG; Wang CH; Zhang HQ; Yang C; Liu M; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1287-1297. PubMed ID: 31288582
[TBL] [Abstract][Full Text] [Related]
6. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
Li N; Xin WY; Yao BR; Wang CH; Cong W; Zhao F; Li HJ; Hou Y; Meng QG; Hou GG
Eur J Med Chem; 2018 Mar; 147():21-33. PubMed ID: 29421568
[TBL] [Abstract][Full Text] [Related]
7. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation.
Zhou YQ; Sun Y; Luo HL; Gao ZF; Zhang HQ; Meng QG; Bai XY; Hou GG; Hou Y
Eur J Med Chem; 2021 Dec; 225():113796. PubMed ID: 34450496
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
Zhang L; Chen Q; Hou G; Zhao W; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):264-271. PubMed ID: 30734613
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
[TBL] [Abstract][Full Text] [Related]
10. Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch.
Chen L; Li Q; Zheng Z; Xie J; Lin X; Jiang C; Xu H; Wu X; Wu J; Zhang H
Chem Biol Drug Des; 2019 Jul; 94(1):1368-1377. PubMed ID: 30873716
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.
Jin R; Chen Q; Yao S; Bai E; Fu W; Wang L; Wang J; Du X; Wei T; Xu H; Jiang C; Qiu P; Wu J; Li W; Liang G
Eur J Med Chem; 2018 Jan; 144():218-228. PubMed ID: 29351887
[TBL] [Abstract][Full Text] [Related]
12. Ethanol extract of Adiantum capillus-veneris L. suppresses the production of inflammatory mediators by inhibiting NF-κB activation.
Yuan Q; Zhang X; Liu Z; Song S; Xue P; Wang J; Ruan J
J Ethnopharmacol; 2013 Jun; 147(3):603-11. PubMed ID: 23542147
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer.
Wu J; Wu S; Shi L; Zhang S; Ren J; Yao S; Yun D; Huang L; Wang J; Li W; Wu X; Qiu P; Liang G
Eur J Med Chem; 2017 Jan; 125():1321-1331. PubMed ID: 27886548
[TBL] [Abstract][Full Text] [Related]
14. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.
Yadav VR; Sahoo K; Awasthi V
Br J Pharmacol; 2013 Dec; 170(7):1436-48. PubMed ID: 24102070
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation on novel analogs of 9-methylstreptimidone, an inhibitor of NF-kappaB.
Ishikawa Y; Tachibana M; Matsui C; Obata R; Umezawa K; Nishiyama S
Bioorg Med Chem Lett; 2009 Mar; 19(6):1726-8. PubMed ID: 19231181
[TBL] [Abstract][Full Text] [Related]
18. The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway.
Li X; Tang Y; Ma B; Wang Z; Jiang J; Hou S; Wang S; Zhang J; Deng M; Duan Z; Tang X; Chen AF; Jiang L
Inflamm Res; 2018 May; 67(5):455-466. PubMed ID: 29523916
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, crystal structures and anti-inflammatory activity of four 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivatives.
Li N; Bai X; Zhang L; Hou Y
Acta Crystallogr C Struct Chem; 2018 Oct; 74(Pt 10):1171-1179. PubMed ID: 30284984
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
